JAY PATEL: Open Payments
NPI 1639256696 · MARLTON, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,174 in 192 payments from 33 companies in 2025. Trend: 2023 $2,951 · 2024 $3,501 · 2025 $3,174
Food & beverage: $3,174
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 23 | $431 |
| ABBVIE INC. | 27 | $413 |
| AstraZeneca Pharmaceuticals LP | 14 | $278 |
| PFIZER INC. | 18 | $216 |
| Amgen Inc. | 12 | $164 |
| GlaxoSmithKline, LLC. | 12 | $152 |
| Lundbeck LLC | 9 | $148 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 6 | $108 |
| Vanda Pharmaceuticals Inc. | 5 | $91 |
| Dexcom, Inc. | 5 | $86 |
Products named: VRAYLAR, Ozempic, REXULTI, NURTEC ODT, AIRSUPRA, TRELEGY ELLIPTA, UBRELVY, XIFAXAN.
Industry payments across NJ — which companies pay providers there.
